妇科颞下颌关节和骨盆之间的功能联系 (TMJ and Pelvis)
生殖器脱垂、子宫内膜异位症等妇科疾病妇女颞下颌关节与骨盆的功能关系
1 Recruitment. 2. Collection of written consents for the study. 3. Random assignment to groups with and without intervention. 4. Completion of questionnaires by study participants, postural pattern assessment, temporomandibular joint assessment, and platform assessment.
5. Performance of visceral therapy in the group with intervention, in the group without intervention placebo. Duration 5 weeks, treatment 1x per week at the same time of day and given day e.g. Mondays only.
6. Reassessment as in step 4. 7. Data collection, statistical analyses. 8. Interpretation of results for female participants. 9. Preparation of results for scientific publications.
研究概览
详细说明
Methods
After taking a detailed history, patients will be asked to:
-
Completing: the SF-36 quality of life assessment questionnaire and Female Sexual Function Index assessment, and marking on a numerical scale their pain sensations for the temporomandibular joint and for the pelvis, World Health Organization Quality of Life BREF (WHOQOL-BREF).
The SF-36 questionnaire, FSFI scale, World Health Organization Quality of Life BREF (WHOQOL-BREF) and numerical scale (assessing pain sensations for the temporomandibular joint and pelvic joint), will also be subjected to completion/checking after the completion of manual visceral treatments in groups with physiotherapy intervention for both conditions.
-
Type of postural pattern according to Hall-Wernham-Littlejohn: type I - normal, type II - anterior pelvic tilt, type III - posterior pelvic tilt.
3 Pelvic type assessment: normal, high, low; pelvic type will be assessed in each patient and in groups with physiotherapeutic intervention for both conditions before and after manual visceral treatments.
4. Assessment of mobility in the temporomandibular joints in the sagittal plane CromWell digital caliper, and diagnosis using standardized protocols.
5. Postural assessment on the Posturomed Technomex platform and Podoscope Sensor Medica.
6. 6.Manual visceral treatments The treatments will be performed after the patient is qualified by the obstetrician-gynecologist specialist.
7. After performing techniques and placebo in both groups, filling out questionnaires again, measuring on the platform, pattern posture..
8. Statistical analysis: upon completion of the study, the collected quantitative and qualitative data will be subjected to statistical analysis. The choice of statistical tools will depend on the obtained probability distribution.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Małgorzata E Wójcik, Dr
- 电话号码:51 +4895 727 91 00
- 邮箱:m.wojcik@awf-gorzow.edu.pl
研究联系人备份
- 姓名:Anna M Paczkowska, Dr
- 电话号码:12 +4861 285 40 31
学习地点
-
-
-
Poznan、波兰、61-871
- 招聘中
- Poznan University of Physical Education
-
接触:
- Małgorzata M Wójcik, Dr
- 电话号码:32 +48(95) 72 79 100
- 邮箱:m.wojcik@awf-gorzow.edu.pl
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Written consent to participate in the study.
- Female patients after surgical treatment with prolapse of reproductive organs and diagnosed endometriosis.
Exclusion Criteria:
- No written consent to participate in the study.
- Cancer.
- Injury to the temporomandibular joint and pelvis.
- Fibromyalgia.
- Rheumatic diseases.
- At each stage of the experiment if the patient decides that she does not want to participate she is excluded.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:2 subgroups with wisceral therapy
A group of women with endometriosis and reproductive organ prolapse will be randomly assigned to the intervention will have visceral therapy performed, and the group without the intervention will have a placebo. |
Visceral therapy will be performed manually by a physiotherapist, a detailed description of the techniques is above. Therapy will be in 2 subgroups with prolapse of the usual genitals and endometriosis. |
|
安慰剂比较:2 subgroups with placebo (without intervention)
The group of women with endometriosis and reproduvtive organ prolapse without the intervention will have a placebo only hands held on the pelvis by a physiotherapist. |
Placebo will be in 2 subgroups that will not have visceral therapy. The placebo will consist of the physiotherapist holding hands on the patient's pelvis. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
NRS
大体时间:Time point one: before starting visceral therapy and placebo, 1 st week
|
Each patient will mark on the NRS scale the sensation of pain before the tests. Scale of 1-10, the higher the value the greater the pain experience. |
Time point one: before starting visceral therapy and placebo, 1 st week
|
|
platforms
大体时间:Time point one: before starting visceral therapy and placebo,1 st week
|
Each patient will have a postural stability assessment prior to testing.No platform manufacturer provides standards. The platform is equipped with sensors - it collects the force of the feet and gives how the center of gravity is located, that is, the front-back, side-to-side tilts are given. |
Time point one: before starting visceral therapy and placebo,1 st week
|
|
postural pattern by Halla-Wernhama-Littlejohna
大体时间:Time point one: before starting visceral therapy and placeb1 st weeko,
|
Before the test, each patient will have a postural pattern assessment. Evaluating the pattern of type 1 anterior tilt of the body, type 2 normal, type 3 posterior tilt. |
Time point one: before starting visceral therapy and placeb1 st weeko,
|
|
pelvic type assessment
大体时间:Time point one: before starting visceral therapy and placebo,1 st week
|
Before the test, each patient will have a pelvic type assessment. High-assimilated type: hip plates above the L5 segment: overloaded type: hip plates below the L4 segment; normal type: hip plates at the level of the L4-L5 segment. |
Time point one: before starting visceral therapy and placebo,1 st week
|
|
CromWell (measurement of oral dilation)
大体时间:Time point one: before starting visceral therapy and placebo,1 st week
|
Before the test, each patient will have their mouth opening measured with an electronic caliper.There are no standards given, it is a measurement of the dilation of the mouth. |
Time point one: before starting visceral therapy and placebo,1 st week
|
|
standarised questonarie by Kulesa-Morawiecka et al.
大体时间:Time point one: before starting visceral therapy and placebo,1 st week
|
Each patient will complete a questionnaire on the evaluation of the temporomandibular joint. Scale of 0-10 points, 0 - means no strength of head and neck muscles, 10 - means strong tension of head and neck muscles. |
Time point one: before starting visceral therapy and placebo,1 st week
|
|
According to the Polish version of the questionnaire, the highest point value, i.e. 171, indicates the lowest rank in the quality of life assessment, while the lowest point value indicates the highest level of quality of life.
大体时间:Time point one: before starting visceral therapy and placebo,1 st week
|
Each patient will complete a questionnaire on the evaluation of quality of life.Assessment: physical functioning, limitations due to physical health, pain perception, general sense of health, vitality, social functioning, emotional functioning and mental health. |
Time point one: before starting visceral therapy and placebo,1 st week
|
|
Female Sexual Function Index. Score: a value of 26 points or less indicates the presence of significantly clinical sexual dysfunction.
大体时间:Time point one: before starting visceral therapy and placebo,1 st week
|
Each patient will complete a questionnaire. |
Time point one: before starting visceral therapy and placebo,1 st week
|
|
visceral techniques and placebo
大体时间:1 st week, 2nd week, 3rd week,4th week, 5 week
|
The intervention group will have visceral therapy performed. The group without intervention will only have their hands held on the pelvis. |
1 st week, 2nd week, 3rd week,4th week, 5 week
|
|
Masseter Muscles Tension
大体时间:2023-2025
|
The device was developed by the authors (PAT 2568 W.132167; patent W.132167). Its construction consists of two parallel beams between which strain gauges are placed to record their deformation under applied compressive force. The signal from the strain gauges was transmitted to a force meter, which displayed the result in mass units (kilograms). The recorded result was entered into an Excel spreadsheet. Measurements were performed under both eyes-open and eyes-closed conditions. Each measurement lasted 30 seconds. A 5-minute rest interval was applied between the eyes-open and eyes-closed measurements |
2023-2025
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
NRS
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will mark on the pain sensation scale. Scale of 1-10, the higher the value the greater the pain experience. |
Time point two: after visceral therapy and placebo, 5th week
|
|
platforms
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will have a postural stability assessment. No platform manufacturer provides standards. The platform is equipped with sensors - it collects the force of the feet and gives how the center of gravity is located, that is, the front-back, side-to-side tilts are given. |
Time point two: after visceral therapy and placebo, 5th week
|
|
postural pattern by Halla-Wernhama-Littlejohna
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will have a posture pattern assessment. Evaluating the pattern of type 1 anterior tilt of the body, type 2 normal, type 3 posterior tilt. |
Time point two: after visceral therapy and placebo, 5th week
|
|
pelvic type assessment
大体时间:Time point two: after visceral therapy and placebo,5 th week
|
After 5 weeks, each patient will have a pelvic type assessment.High-assimilated type: hip plates above the L5 segment: overloaded type: hip plates below the L4 segment; normal type: hip plates at the level of the L4-L5 segment. |
Time point two: after visceral therapy and placebo,5 th week
|
|
CromWell (measurement of oral dilation)
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will have an evaluation of oral dilation with an electronic caliper.There are no standards given, it is a measurement of the dilation of the mouth. |
Time point two: after visceral therapy and placebo, 5th week
|
|
standarised questonarie by Kulesa-Morawiecka et al.
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will complete a temporomandibular joint evaluation questionnaire.Scale of 0-10 points, 0 - means no strength of head and neck muscles, 10 - means strong tension of head and neck muscles. |
Time point two: after visceral therapy and placebo, 5th week
|
|
According to the Polish version of the questionnaire, the highest point value, i.e. 171, indicates the lowest rank in the quality of life assessment, while the lowest point value indicates the highest level of quality of life.
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will complete a quality of life questionnaire. Assessment: physical functioning, limitations due to physical health, pain perception, general sense of health, vitality, social functioning, emotional functioning and mental health. |
Time point two: after visceral therapy and placebo, 5th week
|
|
Female Sexual Function Index. Score: a value of 26 points or less indicates the presence of significantly clinical sexual dysfunction.
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will complete a sexual satisfaction questionnaire |
Time point two: after visceral therapy and placebo, 5th week
|
|
World Health Organization Quality of Life BREF (WHOQOL-BREF)
大体时间:Time point two: after visceral therapy and placebo, 5th week
|
After 5 weeks, each patient will complete a sexual satisfaction questionnaire |
Time point two: after visceral therapy and placebo, 5th week
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.